Protein FDR Confidence: Combined | Accession | Description | Exp. q-value: Combined | Sum PEP Score | Coverage [%] | # Peptides | # PSMs | # Unique Peptides | # AAs | MW [kDa] | calc. pI | # Peptides (by Search Engine): A2 Sequest HT (IgG) | # Peptides (by Search Engine): B2 Sequest HT (SKO) | # Peptides (by Search Engine): C2 Sequest HT (WT) | # Peptides (by Search Engine): D2 Sequest HT (HKO) | # PSMs (by Search Engine): A2 Sequest HT (IgG) | # PSMs (by Search Engine): B2 Sequest HT (SKO) | # PSMs (by Search Engine): C2 Sequest HT (WT) | # PSMs (by Search Engine): D2 Sequest HT (HKO) | Abundance: F1: Sample, IgG | Abundance: F2: Sample, SKO | Abundance: F3: Sample, WT | Abundance: F4: Sample, HKO | Abundances Count: F1: Sample, IgG | Abundances Count: F2: Sample, SKO | Abundances Count: F3: Sample, WT | Abundances Count: F4: Sample, HKO | Modifications | Biological Process | Cellular Component | Molecular Function | Pfam IDs | Entrez Gene ID | Ensembl Gene ID | Gene Symbol | Chromosome | Reactome Pathways | KEGG Pathways | # Razor Peptides |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
High | A0A0B4J1G0 | Low affinity immunoglobulin gamma Fc region receptor IV OS=Mus musculus OX=10090 GN=Fcgr4 PE=1 SV=1 | 0 | 23.242 | 22 | 6 | 22 | 6 | 249 | 28.4 | 8.09 | 6 | 4 | 2 | 5 | 10 | 4 | 3 | 5 | 21943010.63 | 19165441.5 | 22224838.38 | 31833231.75 | 6 | 5 | 5 | 4 | regulation of biological process;response to stimulus | cell surface;membrane | protein binding;receptor activity;signal transducer activity | "Pf00047, Pf07679, Pf07686, Pf13895, Pf13927" | 246256 | ENSMUSG00000059089.4 | Fcgr4 | 1 | Role of phospholipids in phagocytosis; Post-translational modification: synthesis of GPI-anchored proteins; Neutrophil degranulation; Regulation of actin dynamics for phagocytic cup formation; FCGR activation | Staphylococcus aureus infection; Tuberculosis; Osteoclast differentiation; Phagosome; Natural killer cell mediated cytotoxicity; Systemic lupus erythematosus; Leishmaniasis | 0 |